Drugs that contain Selumetinib Sulfate

1. Drug name - KOSELUGO

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8178693 ASTRAZENECA N3 alkylated benzimidazole derivatives as MEK inhibitors
Mar, 2023

(5 months from now)

US7425637 ASTRAZENECA N3 alkylated benzimidazole derivatives as MEK inhibitors
Apr, 2024

(1 year, 6 months from now)

US9562017 ASTRAZENECA Hydrogen sulfate salt
Dec, 2026

(4 years from now)

US9156795 ASTRAZENECA Hydrogen sulfate salt
Dec, 2026

(4 years from now)

CN1874768A ASTRAZENECA N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors
Jan, 2010

(12 years ago)

CN102329270A ASTRAZENECA Hydrosulfate
Dec, 2014

(7 years ago)

CN101633644A ASTRAZENECA N3 Alkylated Benzimidazole Derivative Used As Mek Inhibitor
Mar, 2023

(5 months from now)

CN101633645B ASTRAZENECA N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors
Mar, 2023

(5 months from now)

CN101633644B ASTRAZENECA N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors
Mar, 2023

(5 months from now)

CN100519539C ASTRAZENECA N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors
Mar, 2023

(5 months from now)

CN1652776A ASTRAZENECA N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors
Mar, 2023

(5 months from now)

CN101486682A ASTRAZENECA N3 Alkylated Benzoimidazole Derivatives As Mek Inhibitors
Mar, 2023

(5 months from now)

CN101486682B ASTRAZENECA N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors
Mar, 2023

(5 months from now)

CN101633645A ASTRAZENECA N3 Alkylated Benzimidazole Derivative Used As Mek Inhibitor
Mar, 2023

(5 months from now)

CN101360718A ASTRAZENECA Novel Hydrogen Sulphate Salt
Dec, 2026

(4 years from now)

CN101360718B ASTRAZENECA Hydrosulfate
Dec, 2026

(4 years from now)

IN200403046P1 ASTRAZENECA N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors
Mar, 2023

(5 months from now)

IN248684B ASTRAZENECA N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors
Mar, 2023

(5 months from now)

EP2130536A1 ASTRAZENECA N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors
Mar, 2023

(5 months from now)

EP2130537A1 ASTRAZENECA N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors
Mar, 2023

(5 months from now)

EP2130537B1 ASTRAZENECA N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors
Mar, 2023

(5 months from now)

EP2275102B1 ASTRAZENECA N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors
Mar, 2023

(5 months from now)

EP3000810A1 ASTRAZENECA N3 Alkylated Benzimidazole Derivative As Mek Inhibitor
Mar, 2023

(5 months from now)

EP2275102A1 ASTRAZENECA N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors
Mar, 2023

(5 months from now)

EP2130536B1 ASTRAZENECA N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors
Mar, 2023

(5 months from now)

EP3000810B1 ASTRAZENECA N3 Alkylated Benzimidazole Derivative As Mek Inhibitor
Mar, 2023

(5 months from now)

EP1482932A1 ASTRAZENECA N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors
Mar, 2023

(5 months from now)

EP1482932B1 ASTRAZENECA N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors
Mar, 2023

(5 months from now)

EP1482932A4 ASTRAZENECA N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors
Mar, 2023

(5 months from now)

EP1663210A4 ASTRAZENECA N3 Alkylated Benzimidazole Derivatives As Mek Inhibitors
Aug, 2024

(1 year, 10 months from now)

EP1663210A1 ASTRAZENECA Benzimidazole Derivatives As Mek Inhibitors
Aug, 2024

(1 year, 10 months from now)

EP1663210B1 ASTRAZENECA Benzimidazole Derivatives As Mek Inhibitors
Aug, 2024

(1 year, 10 months from now)

EP1968948A2 ASTRAZENECA Novel Hydrogen Sulfate Salt
Dec, 2026

(4 years from now)

EP1968948B1 ASTRAZENECA Novel Hydrogen Sulfate Salt
Dec, 2026

(4 years from now)

EP1968948A4 ASTRAZENECA Novel Hydrogen Sulfate Salt
Dec, 2026

(4 years from now)

Treatment: NA

Dosage: CAPSULE;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 10MG BASE CAPSULE;ORAL Prescription
EQ 25MG BASE CAPSULE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.